Dr Amritha Nair is an Industry Partnerships and Commercialisation Senior Executive in the Faculty of Medicine at Imperial College London. Amritha works across the entire innovation lifecycle from assessment, protection, and management of Intellectual property;...
This event highlighted some of the AI, machine learning and data-driven technologies from across Imperial that are being used for applications ranging from wireless video transfer to electric vehicle charging infrastructure, planning new offshore windfarms and optimising drug development and production.
Imperial.Tech.Pitch: Affordable technologies for an ageing society centred on the premise that within 20 years, there will be 25% fewer taxpayers to pensioners in the UK than in 2020.
Imperial.Tech.Pitch: Transition to zero pollution saw researchers and inventors from Imperial showcase their technologies and innovations that are helping companies and sectors to transition to a zero pollution future.
BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines.
Learn about our programme of events and sign up to be alerted for future events
This novel neutralising antibody-based approach offers an innovative and valuable therapeutic strategy for patients with neuropathic pain.
Research in our laboratory focuses on the molecular mechanism of pain pathways. We employ primary cultures of sensory neurons and macrophages, live cell imaging, and molecular biology.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.